Transcutaneous Bilirubin Meters Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Device, End User, Functionality, Installation Type

Description

The global Transcutaneous Bilirubin Meters Market is projected to grow from $0.3 billion in 2025 to $0.5 billion by 2035, at a compound annual growth rate (CAGR) of 5.7%. Publicly available official statistics do not provide a standalone global market size or CAGR specifically for transcutaneous bilirubin meters; therefore, neonatal birth activity provides an important demand proxy. The U.S. recorded approximately 3.606 million births in 2025, down 1% from 2024, according to CDC provisional data based on more than 99% of registered births. Globally, the addressable need remains substantial because neonatal jaundice is common, particularly among preterm infants, creating sustained requirements for bilirubin screening. FDA records also demonstrate an established regulatory pathway for bilirubin measurement devices, supporting continued commercialization and technology development.

Handheld transcutaneous bilirubin meters represent the most flexible product category, combining compact form factors, battery operation, rapid measurements, and portability across nurseries, neonatal intensive care units, outpatient clinics, and bedside settings. Benchtop systems provide stable, repeatable operation and are suited to centralized neonatal screening or high-throughput clinical environments where device integration and workflow consistency are prioritized. Other formats include specialized or hybrid configurations designed for specific care pathways. Demand is increasingly oriented toward handheld systems because they facilitate point-of-care testing, reduce operational complexity, and support screening before hospital discharge. Benchtop adoption remains relevant where centralized workflows, standardized measurement, and institutional procurement dominate purchasing decisions.

Market Segmentation
Type	Handheld, Benchtop, Others
Product	Portable Bilirubin Meters, Non-Portable Bilirubin Meters, Others
Technology	Optical, Spectrophotometric, Others
Component	Sensors, Display Units, Software, Others
Application	Neonatal Jaundice, Pediatric Care, Others
Device	Standalone Devices, Integrated Systems, Others
End User	Hospitals, Clinics, Home Care Settings, Others
Functionality	Single-Function, Multi-Function, Others
Installation Type	Fixed, Mobile, Others

Single-function meters primarily estimate transcutaneous bilirubin levels, emphasizing simplicity, rapid operation, and dedicated neonatal screening. Multi-function platforms integrate bilirubin assessment with additional monitoring capabilities, connectivity, data storage, or workflow-management features, improving clinical documentation and interoperability within digital hospital environments. Other functionality categories encompass specialized devices incorporating advanced optical algorithms or application-specific capabilities. Single-function products maintain strong adoption where affordability, ease of training, and rapid screening are key procurement criteria, particularly in resource-constrained settings. Meanwhile, multi-function systems are gaining strategic importance in advanced hospitals as healthcare providers prioritize connected diagnostics, centralized data management, automated reporting, and integration with electronic medical records and broader neonatal care ecosystems.

Geographical Overview

North America maintains a substantial position in the transcutaneous bilirubin meters market, supported by sophisticated neonatal and maternity-care infrastructure, high diagnostic technology penetration, and established clinical protocols for newborn jaundice screening. The United States represents a major demand center due to its extensive hospital network, neonatal intensive care capacity, and established medical-device regulatory framework. CDC data recorded 3.606 million U.S. births in 2025, sustaining a sizeable annual screening population despite a modest year-on-year decline. Strong healthcare expenditure, clinician familiarity with non-invasive diagnostics, and adoption of connected medical technologies reinforce replacement and upgrade demand, while FDA device oversight supports structured commercialization and market access.

Asia-Pacific is positioned for considerable market expansion as birth volumes, neonatal healthcare investment, and diagnostic capacity continue developing across China, India, Southeast Asia, and other emerging economies. Growing construction and modernization of maternity hospitals, neonatal intensive care units, and pediatric facilities are increasing demand for rapid, non-invasive bilirubin screening technologies. Government initiatives aimed at reducing neonatal mortality and improving maternal-child healthcare are encouraging earlier detection and intervention, while manufacturers are expanding distribution networks and introducing portable, cost-sensitive solutions. Increasing awareness of jaundice management, broader point-of-care testing adoption, and improving healthcare access are expected to strengthen regional demand, particularly outside major metropolitan centers.

Key Trends and Drivers

Smart, Connected, and Portable Bilirubin Monitoring Reshapes Neonatal Care:

The market is shifting toward portable, connected, and workflow-integrated bilirubin assessment, with manufacturers emphasizing compact optical architectures, improved measurement algorithms, wireless connectivity, digital recordkeeping, and compatibility with electronic health information systems. This evolution reflects hospitals' broader transition toward point-of-care diagnostics that deliver rapid measurements while reducing dependence on laboratory workflows. Product development is increasingly focused on combining ease of use with enhanced measurement consistency, automated data transfer, and intuitive interfaces, enabling clinicians to incorporate bilirubin screening more efficiently into routine neonatal assessments and discharge pathways.

Rising Focus on Early Jaundice Detection Accelerates Non-Invasive Screening:

The growing clinical need for early identification and monitoring of neonatal hyperbilirubinemia remains a primary demand catalyst. Transcutaneous bilirubin meters enable rapid, non-invasive screening without repeated blood collection, reducing discomfort for newborns and supporting efficient clinical triage. Their ability to provide immediate bedside estimates can help clinicians identify infants requiring confirmatory serum testing or closer monitoring, improving workflow efficiency in maternity wards and neonatal units. Rising emphasis on newborn safety, standardized jaundice screening, and timely intervention is encouraging healthcare providers to adopt technologies that simplify routine assessment while supporting more frequent monitoring across hospital and outpatient settings.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS34830

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Application
2.5 Key Market Highlights by End User
2.6 Key Market Highlights by Component
2.7 Key Market Highlights by Functionality
2.8 Key Market Highlights by Device
2.9 Key Market Highlights by Installation Type

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Handheld
- 4.1.2 Benchtop
- 4.1.3 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Portable Bilirubin Meters
- 4.2.2 Non-Portable Bilirubin Meters
- 4.2.3 Others
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 Optical
- 4.3.2 Spectrophotometric
- 4.3.3 Others
4.4 Market Size & Forecast by Application (2020-2035)
- 4.4.1 Neonatal Jaundice
- 4.4.2 Pediatric Care
- 4.4.3 Others
4.5 Market Size & Forecast by End User (2020-2035)
- 4.5.1 Hospitals
- 4.5.2 Clinics
- 4.5.3 Home Care Settings
- 4.5.4 Others
4.6 Market Size & Forecast by Component (2020-2035)
- 4.6.1 Sensors
- 4.6.2 Display Units
- 4.6.3 Software
- 4.6.4 Others
4.7 Market Size & Forecast by Functionality (2020-2035)
- 4.7.1 Single-Function
- 4.7.2 Multi-Function
- 4.7.3 Others
4.8 Market Size & Forecast by Device (2020-2035)
- 4.8.1 Standalone Devices
- 4.8.2 Integrated Systems
- 4.8.3 Others
4.9 Market Size & Forecast by Installation Type (2020-2035)
- 4.9.1 Fixed
- 4.9.2 Mobile
- 4.9.3 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Application
  - 5.2.1.5 End User
  - 5.2.1.6 Component
  - 5.2.1.7 Functionality
  - 5.2.1.8 Device
  - 5.2.1.9 Installation Type
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Application
  - 5.2.2.5 End User
  - 5.2.2.6 Component
  - 5.2.2.7 Functionality
  - 5.2.2.8 Device
  - 5.2.2.9 Installation Type
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Application
  - 5.2.3.5 End User
  - 5.2.3.6 Component
  - 5.2.3.7 Functionality
  - 5.2.3.8 Device
  - 5.2.3.9 Installation Type
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Application
  - 5.3.1.5 End User
  - 5.3.1.6 Component
  - 5.3.1.7 Functionality
  - 5.3.1.8 Device
  - 5.3.1.9 Installation Type
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Application
  - 5.3.2.5 End User
  - 5.3.2.6 Component
  - 5.3.2.7 Functionality
  - 5.3.2.8 Device
  - 5.3.2.9 Installation Type
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Application
  - 5.3.3.5 End User
  - 5.3.3.6 Component
  - 5.3.3.7 Functionality
  - 5.3.3.8 Device
  - 5.3.3.9 Installation Type
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Application
  - 5.4.1.5 End User
  - 5.4.1.6 Component
  - 5.4.1.7 Functionality
  - 5.4.1.8 Device
  - 5.4.1.9 Installation Type
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Application
  - 5.4.2.5 End User
  - 5.4.2.6 Component
  - 5.4.2.7 Functionality
  - 5.4.2.8 Device
  - 5.4.2.9 Installation Type
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Application
  - 5.4.3.5 End User
  - 5.4.3.6 Component
  - 5.4.3.7 Functionality
  - 5.4.3.8 Device
  - 5.4.3.9 Installation Type
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Application
  - 5.4.4.5 End User
  - 5.4.4.6 Component
  - 5.4.4.7 Functionality
  - 5.4.4.8 Device
  - 5.4.4.9 Installation Type
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Application
  - 5.4.5.5 End User
  - 5.4.5.6 Component
  - 5.4.5.7 Functionality
  - 5.4.5.8 Device
  - 5.4.5.9 Installation Type
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Application
  - 5.4.6.5 End User
  - 5.4.6.6 Component
  - 5.4.6.7 Functionality
  - 5.4.6.8 Device
  - 5.4.6.9 Installation Type
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Application
  - 5.4.7.5 End User
  - 5.4.7.6 Component
  - 5.4.7.7 Functionality
  - 5.4.7.8 Device
  - 5.4.7.9 Installation Type
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Application
  - 5.5.1.5 End User
  - 5.5.1.6 Component
  - 5.5.1.7 Functionality
  - 5.5.1.8 Device
  - 5.5.1.9 Installation Type
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Application
  - 5.5.2.5 End User
  - 5.5.2.6 Component
  - 5.5.2.7 Functionality
  - 5.5.2.8 Device
  - 5.5.2.9 Installation Type
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Application
  - 5.5.3.5 End User
  - 5.5.3.6 Component
  - 5.5.3.7 Functionality
  - 5.5.3.8 Device
  - 5.5.3.9 Installation Type
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Application
  - 5.5.4.5 End User
  - 5.5.4.6 Component
  - 5.5.4.7 Functionality
  - 5.5.4.8 Device
  - 5.5.4.9 Installation Type
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Application
  - 5.5.5.5 End User
  - 5.5.5.6 Component
  - 5.5.5.7 Functionality
  - 5.5.5.8 Device
  - 5.5.5.9 Installation Type
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Application
  - 5.5.6.5 End User
  - 5.5.6.6 Component
  - 5.5.6.7 Functionality
  - 5.5.6.8 Device
  - 5.5.6.9 Installation Type
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Application
  - 5.6.1.5 End User
  - 5.6.1.6 Component
  - 5.6.1.7 Functionality
  - 5.6.1.8 Device
  - 5.6.1.9 Installation Type
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Application
  - 5.6.2.5 End User
  - 5.6.2.6 Component
  - 5.6.2.7 Functionality
  - 5.6.2.8 Device
  - 5.6.2.9 Installation Type
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Application
  - 5.6.3.5 End User
  - 5.6.3.6 Component
  - 5.6.3.7 Functionality
  - 5.6.3.8 Device
  - 5.6.3.9 Installation Type
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Application
  - 5.6.4.5 End User
  - 5.6.4.6 Component
  - 5.6.4.7 Functionality
  - 5.6.4.8 Device
  - 5.6.4.9 Installation Type
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Application
  - 5.6.5.5 End User
  - 5.6.5.6 Component
  - 5.6.5.7 Functionality
  - 5.6.5.8 Device
  - 5.6.5.9 Installation Type

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Dragerwerk AG
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Konica Minolta Inc
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Philips Healthcare
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Natus Medical Incorporated
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 GE Healthcare
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Hill-Rom Holdings Inc
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Masimo Corporation
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Medtronic plc
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Siemens Healthineers
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Becton Dickinson and Company
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Abbott Laboratories
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 F. Hoffmann-La Roche Ltd
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Johnson and Johnson
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Thermo Fisher Scientific
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Baxter International Inc
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Fujifilm Holdings Corporation
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Canon Medical Systems Corporation
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Mindray Medical International Limited
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Welch Allyn Inc
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Edwards Lifesciences Corporation
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us